宫腔镜下MyoSure组织切除系统治疗宫内胚胎及胎盘组织残留的临床分析  

Clinical study of hysteroscopic tissue excision system MyoSure to remove residual embryos in utero

作　　者：曾俐琴[1] 黄晓晖[1] 余凡[1] 罗喜平[1] ZENG Liqin;HUANG Xiaohui;YU Fan;LUO Xiping(Department of Gynecology,Guangdong Women and Children Hospital,Guangzhou 510010,China)

机构地区：[1]广东省妇幼保健院妇科,510010

出　　处：《中国妇产科临床杂志》2021年第6期613-615,共3页Chinese Journal of Clinical Obstetrics and Gynecology

摘　　要：目的分析宫腔镜下MyoSure组织切除系统切除宫内残留妊娠组织的有效性、安全性和局限性。方法回顾性分析82例MyoSure切除和78例宫腔镜下清除宫内残留的临床病例资料。结果 (1) MyoSure组与清宫组手术时间[(21.77±19.84) min、(33.05±39.29) min]和出血量[(12.15±18.41) ml、(29.41±65.06) ml)]比较,差异有统计学意义(P <0.05);(2) MyoSure组与清宫组膨宫液流失量[(299.88±452.63) ml、(113.65±281.05) ml]比较,差异有统计学意义(P=0.002),两组均无水中毒等并发症;(3) MyoSure组再次胚胎及胎盘组织残留率(2.44%、15.38%, P=0.004)和新发宫腔粘连率(2.44%、11.54%, P=0.023)均显著低于清宫组。结论宫腔镜下MyoSure组织切除系统切除宫内残留物精准、高效、快速、安全,尤其是切除特殊部位残留胚物。Objective To evaluate the efficacy and safety of hysteroscopic tissue resection system MyoSure removal of intrauterine residual embryos. Methods Clinical data of 82 cases of MyoSure resection and 78 cases of hysteroscopic removal of intrauterine residues were retrospectively analyzed. Results(1) There was significant difference in surgical time(21.77 ± 19.84 min VS 33.05 ± 39.29 min) and blood loss(12.15 ± 18.41 ml VS 29.41 ± 65.06 ml) between the Myo Sure group and the curettage group(P < 0.05).(2) There was significant difference in the fluid flow between the MyoSure group and the curettage group(299.88 ± 452.63 ml VS 113.65 ± 281.05 ml, P=0.002). There were no complications such as water poisoning in both groups.(3) Compared with the curettage group, MyoSure group had lower embryo and placental tissue residual rate(2.44% VS 15.38%, P=0.004) and low incidence of newly-occurred intrauterine adhesions(2.44% VS 11.54%, P=0.023).Conclusion Hysteroscopic tissue resection system MyoSure removes residual embryos in the uterus accurately, efficiently,quickly and safely, especially the removal of residual embryos in special area.

关 键 词：宫腔镜组织切除系统 MyoSure 胚胎及胎盘组织残留 宫腔粘连 

分 类 号：R713[医药卫生—妇产科学]